135 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
and qualified or appointed, or until their earlier death, resignation or removal. Directors are elected by a plurality of the votes cast by our stockholders … , or their earlier death, resignation, or removal. Each of the nominees has agreed to be named and to serve, and we expect each nominee to be able to serve
8-K
EX-99.2
7861ytj l1o5rh
11 Mar 24
Other Events
4:09pm
8-K
EX-99.3
8v65k
11 Mar 24
Other Events
4:09pm
8-K
EX-1.1
r0apb6gy oum46uaw95s
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
424B5
xzplyuh 819lkf
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
q1a2mlca
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.3
zri3koq9phsug8iwvf
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
mnlyp1buoc
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
9oe6d lgc1gjdwmhi
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
EX-99.1
9n9ac4sm
14 Aug 23
Other Events
8:00am
8-K
EX-99.2
2a8c82q370
25 Jul 23
Top-line safety, pharmacokinetic, and pharmacodynamic (frataxin level) data from Phase 2 trial’s 50 mg cohort expected in 1H 2024
7:02am
8-K
EX-99.1
ad13ebj71e4f
1 Jun 23
June 2023 Larimar Therapeutics Corporate Presentation
4:06pm
8-K
EX-99.2
wlno90
15 May 23
Results of Operations and Financial Condition
7:05am
8-K
62q4d 2s8
12 May 23
Submission of Matters to a Vote of Security Holders
4:02pm